Changes in Blood Flow in MCA of Fetuses to Mothers Having Clinical Chorioamnionitis

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2006 by Hadassah Medical Organization.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT00299637
First received: March 5, 2006
Last updated: November 29, 2006
Last verified: March 2006
  Purpose
This study will try to determine whether fetuses to mothers having clinical chorioamnionitis have changes in blood flow in middle cerebral artery.

Condition Phase
Chorioamnionitis
Phase 0

Study Type: Observational
Study Design: Observational Model: Case Control
Observational Model: Natural History
Time Perspective: Cross-Sectional
Time Perspective: Prospective
Official Title: Changes in Blood Flow in MCA of Fetuses to Mothers Having Clinical Chorioamnionitis During Labor Comparing to Fetuses to Healthy Mothers.

Resource links provided by NLM:


Further study details as provided by Hadassah Medical Organization:

Estimated Enrollment: 34
Study Start Date: October 2006
Estimated Study Completion Date: December 2007
Detailed Description:

This study will try to determine whether fetuses to mothers having clinical chorioamnionitis have changes in blood flow in middle cerebral artery.

MCA flow parameters will be evaluated during labor of women with and wthout chorioamnionitis

  Eligibility

Ages Eligible for Study:   20 Years to 45 Years   (Adult)
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • women giving birth week 37-42
  • healthy
  • one fetus

Exclusion Criteria:

  • more than one fetus
  • IUGR
  • illness or damage to fetus
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00299637

Contacts
Contact: david mankuta, MD mankuta@yahoo.com

Locations
Israel
Haddasah Medical Organization Recruiting
Jerusalem, Israel, 12000
Contact: David Mankuta         
Principal Investigator: David Mankuta         
Sponsors and Collaborators
Hadassah Medical Organization
Investigators
Study Chair: David Mankuta, MD Hadassah Medical Organization
  More Information

ClinicalTrials.gov Identifier: NCT00299637     History of Changes
Other Study ID Numbers: MCA chorioamnionitis HMO-CTIL 
Study First Received: March 5, 2006
Last Updated: November 29, 2006
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Additional relevant MeSH terms:
Chorioamnionitis
Fetal Diseases
Pregnancy Complications
Fetal Membranes, Premature Rupture
Obstetric Labor Complications
Placenta Diseases

ClinicalTrials.gov processed this record on July 27, 2016